Institutional Fund
Tcg Crossover Management, LLC
Palo Alto, CACIK 18399485 filings on record
Portfolio Value
$3.50B
Q1 2026
Holdings
49
Reported positions
New Buys
11
Opened this quarter
QoQ Change
+15.7%
from $3.02B
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Abivax SA20.6%
- Cg Oncology Inc7.1%
- Tango Therapeutics Inc6.3%
- Cogent Biosciences Inc5.4%
- Centessa Pharmaceuticals PLC4.9%
- Dianthus Therapeutics Inc4.0%
- Other51.6%
Portfolio Holdings
49 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Abivax SA | 6.48M | $721.67M | 20.6% | −630.5K | Reduced |
| 2 | Cg Oncology Inc | 3.67M | $248.40M | 7.1% | 0 | Held |
| 3 | Tango Therapeutics Inc | 10.53M | $220.31M | 6.3% | −2.23M | Reduced |
| 4 | Cogent Biosciences Inc | 4.95M | $190.41M | 5.4% | −921.3K | Reduced |
| 5 | Centessa Pharmaceuticals PLC | 4.29M | $170.26M | 4.9% | 0 | Held |
| 6 | Dianthus Therapeutics Inc | 1.68M | $140.70M | 4.0% | 0 | Held |
| 7 | Tyra Biosciences Inc | 3.25M | $124.44M | 3.6% | +350.9K | Added |
| 8 | Immunovant Inc | 4.46M | $110.74M | 3.2% | +2.80M | Added |
| 9 | Biocryst Pharmaceuticals Inc | 11.02M | $104.92M | 3.0% | +11.02M | New |
| 10 | Mirum Pharmaceuticals Inc | 1.06M | $98.11M | 2.8% | +1.00M | Added |
39 more holdings on Premium
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio